HUYA Bioscience International And TIPR Announce Joint Venture To Develop Medical Innovation For Global Markets

San Diego, CA, USA – September 15, 2014 – HUYA Bioscience International (HUYA), a leader in accelerating the global development of China’s pharmaceutical innovations, today announced a joint venture with Tianjin Institute of Pharmaceutical Research (TIPR) to develop medical technologies and therapies, originating in both China and the western world, for global markets.